Scarica l'app Stockscreener
0.4059
8.17%
-0.0361
Pre-mercato:
.45
0.0441
+10.86%
Precedente Chiudi:
$0.442
Aprire:
$0.46
Volume 24 ore:
1.27M
Relative Volume:
0.22
Capitalizzazione di mercato:
$12.03M
Reddito:
-
Utile/perdita netta:
$-14.58M
Rapporto P/E:
-0.353
EPS:
-1.15
Flusso di cassa netto:
$-9.80M
1 W Prestazione:
-9.80%
1M Prestazione:
-28.32%
6M Prestazione:
-53.43%
1 anno Prestazione:
-82.04%
Intervallo 1D:
$0.4026
$0.46
Intervallo di 1 settimana:
$0.4026
$0.488
Portata 52W:
$0.30
$2.44
Acurx Pharmaceuticals Inc Stock (ACXP) Company Profile
Nome
Acurx Pharmaceuticals Inc
Settore
Industria
Telefono
917-533-1469
Indirizzo
259 LIBERTY AVENUE, STATEN ISLAND
Confronta ACXP con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ACXP
Acurx Pharmaceuticals Inc
|
0.4059 | 13.10M | 0 | -14.58M | -9.80M | -1.15 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.65 | 121.28B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.10 | 60.96B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.81 | 42.77B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
591.99 | 36.21B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
291.47 | 32.08B | 3.81B | -644.79M | -669.77M | -6.24 |
Acurx Pharmaceuticals Inc Borsa (ACXP) Ultime notizie
Can volume confirm reversal in Acurx Pharmaceuticals Inc.Free Risk Controlled Short Term Trade Plans - Newser
What are Acurx Pharmaceuticals Inc. company’s key revenue driversAchieve rapid capital gains with smart investing - jammulinksnews.com
What are the latest earnings results for Acurx Pharmaceuticals Inc.Maximize portfolio growth with professional advice - jammulinksnews.com
How strong is Acurx Pharmaceuticals Inc. company’s balance sheetFree Trading Psychology Coaching - jammulinksnews.com
What risks could impact Acurx Pharmaceuticals Inc. stock performanceElite Investor Club - Newser
Moving Average Trends for Acurx Pharmaceuticals Inc. Stock: What They IndicateInstant Stock Updates - Newser
How Acurx Pharmaceuticals Inc. stock performs during market volatilityReliable High Profit Alerts - Newser
Does Acurx Pharmaceuticals Inc. stock perform well during market downturnsBuild a portfolio that outperforms the market - jammulinksnews.com
What makes Acurx Pharmaceuticals Inc. stock price move sharplyStable Growth Stock Picks - Newser
Is Acurx Pharmaceuticals Inc. a good long term investmentOutstanding risk-reward balance - PrintWeekIndia
What drives Acurx Pharmaceuticals Inc. stock priceHigh-margin investment plays - PrintWeekIndia
Acurx Pharmaceuticals Faces AI-Driven Challenges Amid Regulatory and Cybersecurity Concerns - TipRanks
What analysts say about Acurx Pharmaceuticals Inc. stockFree Predictions - PrintWeekIndia
Acurx Pharmaceuticals Earnings: Antibiotic Developer to Reveal Q2 2025 Results and Pipeline Progress - Stock Titan
Acurx Pharmaceuticals to Discuss Second Quarter 2025 Financial Results on August 12, 2025 Conference Call and Provide Business Update - Ariva
Acurx Pharmaceuticals Inc. Stock Analysis and ForecastExceptional profit margins - jammulinksnews.com
Acurx Pharmaceuticals Holds Annual Meeting and Elections - TipRanks
Acurx Pharmaceuticals shareholders approve board proposals at annual meeting - Investing.com Australia
Acurx Pharmaceuticals shareholders approve board proposals at annual meeting By Investing.com - Investing.com South Africa
Acurx Pharmaceuticals files $50M mixed shelf offering - MSN
Acurx Pharmaceuticals Inc Azioni (ACXP) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.97%
0.22%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):